Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Catalent has introduced its UpTempo Virtuoso™ platform process for the development and CGMP manufacturing of adeno-associated viral (AAV) vectors. The UpTempo Virtuoso platform standardizes and streamlines many time-consuming steps in AAV ...
read more
Tuesday, January 14, 2020
Catalent announced the launch of FlexDirect™, a new direct-to-patient service for clinical trials.
read more
Thursday, December 12, 2019
Catalent announced the launch of its new CTSuccess™ clinical trial planning service.
read more
Catalent’s OptiDose Design Solution, led by Catalent’s scientific advisors, uses a design approach that combines data-driven scientific tools with Catalent’s extensive development expertise. Integrating pharmaceutics, and dose form design target ...
read more
Catalent announced the broadening of the scope of its OptiForm Solution Suite platform.
read more
Thursday, January 26, 2023
Catalent announced the launch of its new Case Management Service, which has been specifically designed to address the unique challenges associated with the safe and timely delivery of advanced therapies to patients by providing professional supply ...
read more
Wednesday, January 19, 2022
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced the launch of its new Xpress ...
read more
Wednesday, October 07, 2020
Catalent has announced the launch of its new OneXpress service for the integrated development, scale up and manufacturing of new oral solid dosage forms.
read more
Wednesday, October 21, 2020
Catalent announced the launch of OptiGel® DR technology for the formulation and manufacture of delayed/enteric release softgels.
read more
Monday, November 21, 2016
Catalent Pharma Solutions has announced the appointment of Ms. Shannon Trilli in the newly created role of Director of Corporate Responsibility.
read more
Wednesday, December 28, 2016
Catalent Pharma Solutions has announced the appointment of Dr. Joseph (Joe) Reo to the role of Director of Global Scientific Affairs. In his new post, Dr. Reo will be responsible for Catalent’s internal scientific affairs to evolve the company’s ...
read more
Catalent Pharma Solutions, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has announced the appointment of Kunal Jaiswal to the role of Vice President, Strategic ...
read more
Thursday, February 14, 2019
Catalent announced that Alessandro Maselli has been appointed President and Chief Operating Officer, a new position within Catalent.
read more
Wednesday, October 21, 2015
Catalent Pharma Solutions has announced that Wetteny Joseph has been appointed as its new President, Clinical Supply Services.
read more
Catalent Pharma Solutions, a global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, has announced the opening of its clinical supply facility, located within its 200,000 sq. ft....
read more